Setting up and sustaining blood and marrow transplant services for children in middle-income economies: an experience-driven position paper on behalf of the EBMT PDWP

[1]  P. Hari,et al.  Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  P. Hari,et al.  Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  Shannon R. McCurdy,et al.  How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide. , 2019, Blood.

[4]  A. Kumari,et al.  The impact of Host vs. Graft mismatches on rejection of haploidentical bone marrow transplants in thalassemia patients using posttransplant cyclophosphamide , 2019, Bone Marrow Transplantation.

[5]  R. Sebra,et al.  A Large, Refractory Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Escherichia coli Demonstrates Carbapenemase Gene Outbreaks Involving Sink Sites Require Novel Approaches to Infection Control , 2018, Antimicrobial Agents and Chemotherapy.

[6]  A. Kumari,et al.  The Case for High Resolution Extended 6-Loci HLA Typing for Identifying Related Donors in the Indian Subcontinent. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  S. K. Gilani,et al.  ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia. , 2017, Blood advances.

[8]  R. Setia,et al.  Cost of Hematopoietic Stem Cell Transplantation in India , 2014, Mediterranean journal of hematology and infectious diseases.

[9]  J. Challinor,et al.  Baseline standards for paediatric oncology nursing care in low to middle income countries: position statement of the SIOP PODC Nursing Working Group. , 2014, The Lancet. Oncology.

[10]  Anwar Khan,et al.  A prospective international cooperative information technology platform built using open-source tools for improving the access to and safety of bone marrow transplantation in low- and middle-income countries , 2014, J. Am. Medical Informatics Assoc..

[11]  C. Carcassi,et al.  Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia. , 2013, Blood.

[12]  G. Masera,et al.  International Cooperation for the Cure and Prevention of Severe Hemoglobinopathies , 2013, Journal of pediatric hematology/oncology.

[13]  C. Pui,et al.  Relapsed childhood acute lymphoblastic leukaemia. , 2013, The Lancet. Oncology.

[14]  S. Khalid,et al.  Transplantation in low resource countries , 2012 .

[15]  Y. Lubell,et al.  A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand , 2010, BMC health services research.

[16]  A. Gratwohl,et al.  Hematopoietic stem cell transplantation: a global perspective. , 2010, JAMA.

[17]  Hermann Einsele,et al.  Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective , 2009, Biology of Blood and Marrow Transplantation.

[18]  Matthew Darlison,et al.  Global epidemiology of haemoglobin disorders and derived service indicators. , 2008, Bulletin of the World Health Organization.

[19]  A. Casbard,et al.  The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion‐associated graft‐versus‐host disease , 2007, Transfusion.

[20]  J. Klein,et al.  Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  G. Elfenbein,et al.  Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow. , 2004, Experimental hematology.

[22]  John H Rex,et al.  Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies. , 2003, Blood.

[23]  R Storb,et al.  Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. , 2001, The New England journal of medicine.

[24]  G. Lucarelli,et al.  Bone marrow transplantation in patients with thalassemia. , 1990, The New England journal of medicine.

[25]  B. Nordlinger,et al.  Baseline standards for paediatric oncology nursing care in low to middle income countries: position statement of the SIOP PODC Nursing Working Group. , 2014, The Lancet. Oncology.

[26]  L. Rybicki,et al.  Are backup BM harvests worthwhile in unrelated donor allogeneic transplants? , 2010, Bone Marrow Transplantation.

[27]  R. Saxena,et al.  Allogeneic hematopoietic SCT performed in non-HEPA filter rooms: initial experience from a single center in India , 2009, Bone Marrow Transplantation.